MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Long-term outcomes of deep brain stimulation for VPS16-related dystonia: A multi-center international study

    T. Svorenova, LM. Romito, E. Mulroy, L. Cif, E. Moro, KE. Zeuner, S. Zittel, JN. Petry-Schmelzer, M. Ostrozovicova, V. Han, V. Magocova, K. Knorovsky, A. Kollova, B. Garavaglia, N. Golfrè-Andreasi, C. Reale, A. Mazzoni, A. Kaymak, G. Zorzi, R. Eleopra, V. Levi, T. Foltynie, P. Limousin, H. Akram, L. Zrinzo, F. Magrinelli, D. Murphy, H. Houlden, MA. Kurian, C. Baiata, S. Paschen, K. Lohmann, J. Volkmann, W. Hamel, MT. Barbe, R. Jech, P. Havrankova, J. Winkelmann, M. Zech, M. Skorvanek (Košice, Slovakia)

    Objective: To evaluate long-term effects of DBS in an international cohort of people with VPS16-related dystonia. Background: Variants in VPS16 gene have recently been related…
  • 2023 International Congress

    PD-PRIDE: Healthcare experiences of people identifying as LGBTQ+ with Parkinson disease: A qualitative study preliminary analysis

    T. Mcisaac, K. Sutton, P. Kalcic, M. Mussack, H. Shill (Phoenix, USA)

    Objective: To identify the lived experience and perspectives on healthcare access and equity of people with Parkinson disease (PwP) identifying as lesbian, gay, bisexual, transgender,…
  • 2023 International Congress

    Drivers of Health-Related Quality of Life in Parkinson’s Disease: non-motor symptoms and time spent in daily activities

    C. Painous, I. Pijuan, E. Tolosa (Barcelona, Catalonia)

    Objective: The purpose of this study was to identify factors associated with health-related quality of life (HRQoL) in people with Parkinson’s Disease (PwP). Background: HRQoL…
  • 2023 International Congress

    Weighing tremor reduction and side effects: Impact of efficacy and safety outcomes on patient satisfaction at 6 months in MR-guided focused ultrasound thalamotomy for tremor treatment

    F. Buechele, S. Mahendran, M. Uhl, C. Freudinger, A. Maric, M. Oertel, C. Baumann, L. Stieglitz (Zurich, Switzerland)

    Objective: To relate efficacy and safety outcomes to patient satisfaction at 6 months after MR-guided focused ultrasound (MRgFUS) thalamotomy in the ventral intermediate nucleus (VIM)…
  • 2023 International Congress

    Differences in EEG spectral features in Alzheimer’s and Parkinson’s disease with mild cognitive impairment

    M. Ajcevic, M. Catalan, P. Polverino, K. Iscra, G. Mazzon, C. Bertolotti, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to examine changes in brain cortical activity using high-density EEG in subjects with mild cognitive impairment (MCI) due…
  • 2023 International Congress

    TEP-PSP: preliminary results of a therapeutic education program in progressive supranuclear palsy

    A. Camara, C. Painous, M. Baixauli, J. Herrero, S. Pelaez, I. Martin, I. Quiñoa, C. Torregrosa, M. Carrasco, JC. Lopez Reyes, L. Maragall, Y. Compta (Barcelona, Spain)

    Objective: To explore the feasibility and satisfaction of a therapeutic education program (TEP) in progressive supranuclear palsy (PSP). Background: PSP is a rare tauopathy with…
  • 2023 International Congress

    PRRT2 paroxysmal dyskinesia mimicking functional motor disorders: a pediatric case.

    V. Baglioni, D. Esposito, K. Bernardi, M. Novelli, S. [email protected], V. Leuzzi (Rome, Italy)

    Objective: This report highlights how challenging the differential diagnosis between organic and functional motor disorders may be. Indeed, atypical presentations and overlapping features of movement…
  • 2023 International Congress

    Expanding the clinical phenotype of ataxia associated with PMPCA mutations

    E. Sanesteban Beceiro, A. Fernández Revuelta, R. García-Ramos, E. López Valdés, M. Fenollar Cortés, F. Alonso Frech (Madrid, Spain)

    Objective: To describe two probable cases of autosomal recessive ataxia associated with mutations in the PMPCA gene (ATX-PMPCA) secondary to novel compound heterozygous variants. Background:…
  • 2023 International Congress

    The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

    C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

    Objective: To develop a cognitive composite measure that is sensitive to decline in executive functioning for use in Parkinson’s disease (PD) clinical trials. Background: The…
  • 2023 International Congress

    Harmonizing genetic testing for early-onset Parkinson’s disease: results of the PARKNET multicentric study

    M. Percetti, E. Monfrini, I. Palmieri, A. Albanese, M. Avenali, A. Bartoletti-Stella, F. Blandini, G. Brescia, G. Calandra-Buonaura, R. Campopiano, S. Capellari, I. Colangelo, G. Comi, G. Cuconato, R. Ferese, C. Galandra, S. Gambardella, B. Garavaglia, A. Gaudio, E. Giardina, F. Invernizzi, P. Mandich, R. Mineri, C. Panteghini, C. Reale, L. Trevisan, S. Zampatti, P. Cortelli, E. Valente, A. Di Fonzo (Milano, Italy)

    Objective: To harmonize the interpretation of genetic testing in Parkinson's disease (PD) across the PARKNET network, as well as to provide a comprehensive assessment of…
  • « Previous Page
  • 1
  • …
  • 396
  • 397
  • 398
  • 399
  • 400
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley